The Biden administration estimates that Medicare recipients will save about $1.5 billion on out-of-pocket medication costs due to newly negotiated prices for various drugs starting in 2026.
The negotiated prices for crucial medications show a significant reduction, with Januvia for diabetes seeing a remarkable 79% drop, costing $113 per 30-day supply.
Medications like Fiasp and Farxiga also showcase impressive savings; Fiasp is priced at $119 (76% reduction) and Farxiga at $178.50 (68% reduction), helping manage diabetes and related conditions.
Other medications are included in the negotiations such as Enbrel for arthritis at a price of $2,355 (67% reduction) and Stelara for complex conditions at $4,695 (66% reduction).
Collection
[
|
...
]